This review summarizes why there may not be a universally applicable dose for capecitabine because of interpatient differences in basic physiology, pharmacogenomics and diet.

Discover comprehensive details about Capecitabine, including its pronunciation, uses, dosage instructions, indications, and guidelines on how and when to take it or avoid it. The updated ...

Next Generation Capecitabine (NGC) Dosage Regimens Have Been Identified In The Ongoing Phase 1B Trial With Potentially Better Safety And Efficacy Profiles Than Existing Chemotherapy These NGC ...

(HealthDay News) – Secondary prophylaxis with diltiazem may offer cancer patients relief from capecitabine-induced chest pain and dyspnea and allow them to tolerate capecitabine treatment ...

Capecitabine, an oral prodrug of fluorouracil (5-FU), is an unlikely candidate for precise dosing guidelines. As noted in the product label, the interpatient coefficient of variability in 5-FU maximal ...

Diarrhea occurs in 28–54% of patients receiving capecitabine, with grade 3/4 diarrhea experienced by 7–19% of patients. 9 Dose reductions are required in 41–65% of patients receiving ...

The generic version of capecitabine will be marketed by Teva Pharmaceuticals USA at 150 and 500 mg doses.According to the FDA, on average, the cost of a generic drug is 80% to 85% lower than the ...

Processa Pharmaceuticals has dosed the first subject in its Phase II clinical trial of Next Generation Capecitabine (NGC-Cap) to treat patients with advanced or metastatic breast cancer. This ...

Similar results were found in a study of capecitabine monotherapy (2,000 mg/day dose on an intermittent schedule), in which patients with higher baseline levels of serum folate had a significantly ...

Capecitabine is commonly substituted for conventional 5-fluorouracil chemotherapy based on evidence of the efficacy equivalence of these two drugs and the lack of an increase in overall toxic ...